Ranki; Annamari

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ranki; Annamari.The latest application filed is for "method of providing monoclonal auto-antibodies with desired specificity".

Company Profile

2.9.14

Ranki; Annamari - Helsinki FI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nucleic acid molecules encoding monoclonal antibodies specific for IL-17F Grant 10,875,916 - Hayday , et al. December 29, 2	2020-12-29
Method Of Providing Monoclonal Auto-antibodies With Desired Specificity App 20190023779 - HAYDAY; Adrian ; et al.	2019-01-24
Nucleic acid molecules encoding monoclonal antibodies specific for IL-22 Grant 10,131,709 - Hayday , et al. November 20, 2	2018-11-20
Method of isolating human antibodies Grant 9,957,319 - Hayday , et al. May 1, 2	2018-05-01
Methods of treating HIV diseases using novel expression vectors Grant 9,725,486 - Krohn , et al. August 8, 2	2017-08-08
Method Of Providing Monoclonal Auto-antibodies With Desired Specificity App 20170051053 - HAYDAY; Adrian ; et al.	2017-02-23
Nucleic acid molecules encoding moonoclonal antibodies speceific for IL17F Grant 9,475,872 - Hayday , et al. October 25, 2	2016-10-25
Methods And Uses Involving Genetic Aberrations Of Nav3 And Aberrant Expression Of Multiple Genes App 20160083798 - Krohn; Kai ; et al.	2016-03-24
Method Of Providing Monoclonal Auto-antibodies With Desired Specificity App 20140363422 - Hayday; Adrian ; et al.	2014-12-11
Method Of Isolating Human Antibodies App 20140335098 - Hayday; Adrian ; et al.	2014-11-13
Novel Expression Vectors And Uses Thereof App 20140234361 - KROHN; Kai ; et al.	2014-08-21
Methods And Uses Involving Genetic Abnormalities At Chromosome 12 App 20130029337 - KROHN; Kai ; et al.	2013-01-31
Methods and means related to diseases Grant 8,143,029 - Ranki , et al. March 27, 2	2012-03-27
Methods And Uses Involving Genetic Aberrations Of Nav3 And Aberrant Expression Of Multiple Genes App 20120058108 - Krohn; Kai ; et al.	2012-03-08
Method for the diagnosis of lymphoproliferative diseases Grant 7,803,532 - Ranki , et al. September 28, 2	2010-09-28
Methods And Uses Involving Genetic Abnormalities At Chromosome 12 App 20100143907 - Krohn; Kai ; et al.	2010-06-10
Methods and Means Related to Diseases App 20100035971 - Ranki; Annamari ; et al.	2010-02-11
Novel Expression Vectors And Uses Thereof App 20090252707 - KROHN; KAI ; et al.	2009-10-08
Expression vectors and uses thereof Grant 7,510,718 - Krohn , et al. March 31, 2	2009-03-31
Expression vectors and uses thereof Grant 7,498,314 - Krohn , et al. March 3, 2	2009-03-03
Method for the diagnosis of lymphoproliferative diseases App 20050221309 - Ranki, Annamari ; et al.	2005-10-06
Novel expression vectors and uses thereof App 20050026137 - Krohn, Kai ; et al.	2005-02-03
Novel expression vectors and uses thereof App 20030129169 - Krohn, Kai ; et al.	2003-07-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.